Cytoplasmic dynein promotes HIV-1 uncoating

Viruses

Volumn 6, Issue 11, 2014, Pages 4195-4211

  Pawlica, Paulina ^a   Berthoux, Lionel ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

Author keywords

Capsid; Dynein; HIV 1; Microtubules; Uncoating

Indexed keywords

CYTOPLASMIC DYNEIN; DYNACTIN; PROTEIN P50; SMALL INTERFERING RNA;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOFLUORESCENCE MICROSCOPY; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; ULTRACENTRIFUGATION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS UNCOATING; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; GENE SILENCING; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL; VIRUS CAPSID;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

BIOLOGICAL TRANSPORT; CAPSID; CYTOPLASMIC DYNEINS; GENE KNOCKDOWN TECHNIQUES; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; VIRUS UNCOATING;

EID: 84908664449     PISSN: 19994915     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v6114195     Document Type: Article

References (69)

1. Briggs, J.A.; Wilk, T.; Welker, R.; Krausslich, H.G.; Fuller, S.D. Structural organization of authentic, mature HIV-1 virions and cores. EMBO J. 2003, 22, 1707–1715.
2. Briggs, J.A.; Krausslich, H.G. The molecular architecture of HIV. J. Mol. Biol. 2011, 410, 491–500.
3. Pornillos, O.; Ganser-Pornillos, B.K.; Yeager, M. Atomic-level modelling of the HIV capsid. Nature 2011, 469, 424–427.
4. Pornillos, O.; Ganser-Pornillos, B.K.; Kelly, B.N.; Hua, Y.; Whitby, F.G.; Stout, C.D.; Sundquist, W.I.; Hill, C.P.; Yeager, M. X-ray structures of the hexameric building block of the HIV capsid. Cell 2009, 137, 1282–1292.
5. Gamble, T.R.; Yoo, S.; Vajdos, F.F.; von Schwedler, U.K.; Worthylake, D.K.; Wang, H.; McCutcheon, J.P.; Sundquist, W.I.; Hill, C.P. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 1997, 278, 849–853.
6. Goff, S.P. Intracellular trafficking of retroviral genomes during the early phase of infection: Viral exploitation of cellular pathways. J. Gene Med. 2001, 3, 517–528.
7. McDonald, D.; Vodicka, M.A.; Lucero, G.; Svitkina, T.M.; Borisy, G.G.; Emerman, M.; Hope, T.J. Visualization of the intracellular behavior of HIV in living cells. J. Cell Biol. 2002, 159, 441–452.
8. Hulme, A.E.; Perez, O.; Hope, T.J. Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription. Proc. Natl. Acad. Sci. USA 2011, 108, 9975–9980.
9. Arhel, N.J.; Souquere-Besse, S.; Munier, S.; Souque, P.; Guadagnini, S.; Rutherford, S.; Prevost, M.C.; Allen, T.D.; Charneau, P. HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex at the nuclear pore. EMBO J. 2007, 26, 3025–3037.
10. Schaller, T.; Ocwieja, K.E.; Rasaiyaah, J.; Price, A.J.; Brady, T.L.; Roth, S.L.; Hue, S.; Fletcher, A.J.; Lee, K.; Kewal Ramani, V.N. et al. HIV-1 capsid-cyclophilin interactions determine nuclear import pathway, integration targeting and replication efficiency. PLoS Pathog. 2011, 7, e1002439, doi:10.1371/journal.ppat.1002439.
11. Rasaiyaah, J.; Tan, C.P.; Fletcher, A.J.; Price, A.J.; Blondeau, C.; Hilditch, L.; Jacques, D.A.; Selwood, D.L.; James, L.C.; Noursadeghi, M. et al. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 2013, 503, 402–405.
12. Zhou, L.; Sokolskaja, E.; Jolly, C.; James, W.; Cowley, S.A.; Fassati, A. Transportin 3 promotes a nuclear maturation step required for efficient HIV-1 integration. PLoS Pathog. 2011, 7, e1002194, doi:10.1371/journal.ppat.1002194.
13. Ambrose, Z.; Aiken, C. HIV-1 uncoating: Connection to nuclear entry and regulation by host proteins. Virology 2014, 454–455, 371–379.
14. Roa, A.; Hayashi, F.; Yang, Y.; Lienlaf, M.; Zhou, J.; Shi, J.; Watanabe, S.; Kigawa, T.; Yokoyama, S.; Aiken, C. et al. RING domain mutations uncouple TRIM5alpha restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating. J. Virol. 2012, 86, 1717–1727.
15. Yang, Y.; Fricke, T.; Diaz-Griffero, F. Inhibition of reverse transcriptase activity increases stability of the HIV-1 core. J. Virol. 2013, 87, 683–687.
16. Zhang, H.; Dornadula, G.; Orenstein, J.; Pomerantz, R.J. Morphologic changes in human immunodeficiency virus type 1 virions secondary to intravirion reverse transcription: Evidence indicating that reverse transcription may not take place within the intact viral core. J. Hum. Virol. 2000, 3, 165–172.
17. Zhang, H.; Dornadula, G.; Pomerantz, R.J. Natural endogenous reverse transcription of HIV-1. J. Reprod. Immunol. 1998, 41, 255–260.
18. Auewarakul, P.; Wacharapornin, P.; Srichatrapimuk, S.; Chutipongtanate, S.; Puthavathana, P. Uncoating of HIV-1 requires cellular activation. Virology 2005, 337, 93–101.
19. Forshey, B.M.; von Schwedler, U.; Sundquist, W.I.; Aiken, C. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J. Virol. 2002, 76, 5667–5677.
20. Stremlau, M.; Owens, C.M.; Perron, M.J.; Kiessling, M.; Autissier, P.; Sodroski, J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427, 848–853.
21. Sayah, D.M.; Sokolskaja, E.; Berthoux, L.; Luban, J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 2004, 430, 569–573.
22. Stremlau, M.; Perron, M.; Lee, M.; Li, Y.; Song, B.; Javanbakht, H.; Diaz-Griffero, F.; Anderson, D.J.; Sundquist, W.I.; Sodroski, J. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc. Natl. Acad. Sci. USA 2006, 103, 5514–5519.
23. Shi, J.; Zhou, J.; Shah, V.B.; Aiken, C.; Whitby, K. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization. J. Virol. 2011, 85, 542–549.
24. Li, Y.; Kar, A.K.; Sodroski, J. Target cell type-dependent modulation of human immunodeficiency virus type 1 capsid disassembly by cyclophilin A. J. Virol. 2009, 83, 10951–10962.
25. Shah, V.B.; Shi, J.; Hout, D.R.; Oztop, I.; Krishnan, L.; Ahn, J.; Shotwell, M.S.; Engelman, A.; Aiken, C. The host proteins transportin SR2/TNPO3 and cyclophilin A exert opposing effects on HIV-1 uncoating. J. Virol. 2013, 87, 422–432.
26. De Iaco, A.; Santoni, F.; Vannier, A.; Guipponi, M.; Antonarakis, S.; Luban, J. TNPO3 protects HIV-1 replication from CPSF6-mediated capsid stabilization in the host cell cytoplasm. Retrovirology 2013, 10, 20, doi:10.1186/1742-4690-10-20.
27. Guth, C.A.; Sodroski, J. Contribution of PDZD8 to stabilization of the human immunodeficiency virus type 1 capsid. J. Virol. 2014, 88, 4612–4623.
28. Slonska, A.; Polowy, R.; Golke, A.; Cymerys, J. Role of cytoskeletal motor proteins in viral infection. Postepy Hig. Med. Dosw. 2012, 66, 810–817.
29. Gaudin, R.; Alencar, B.C.; Arhel, N.; Benaroch, P. HIV trafficking in host cells: Motors wanted! Trends Cell Biol. 2013, 23, 652–662.
30. Sabo, Y.; Walsh, D.; Barry, D.S.; Tinaztepe, S.; de Los Santos, K.; Goff, S.P.; Gundersen, G.G.; Naghavi, M.H. HIV-1 induces the formation of stable microtubules to enhance early infection. Cell Host Microbe 2013, 14, 535–546.
31. Campbell, E.M.; Perez, O.; Melar, M.; Hope, T.J. Labeling HIV-1 virions with two fluorescent proteins allows identification of virions that have productively entered the target cell. Virology 2007, 360, 286–293.
32. Lehmann, M.; Milev, M.P.; Abrahamyan, L.; Yao, X.J.; Pante, N.; Mouland, A.J. Intracellular transport of human immunodeficiency virus type 1 genomic RNA and viral production are dependent on dynein motor function and late endosome positioning. J. Biol. Chem. 2009, 284, 14572–14585.
33. Pawlica, P.; Le Sage, V.; Poccardi, N.; Tremblay, M.J.; Mouland, A.J.; Berthoux, L. Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5alpha-mediated restriction of retroviruses. J. Virol. 2014, 88, 5661–5676.
34. Campbell, E.M.; Perez, O.; Anderson, J.L.; Hope, T.J. Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha. J. Cell Biol. 2008, 180, 549–561.
35. Sun, X.; Yau, V.K.; Briggs, B.J.; Whittaker, G.R. Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells. Virology 2005, 338, 53–60.
36. Blumenthal, R.; Bali-Puri, A.; Walter, A.; Covell, D.; Eidelman, O. pH-dependent fusion of vesicular stomatitis virus with Vero cells. Measurement by dequenching of octadecyl rhodamine fluorescence. J. Biol. Chem. 1987, 262, 13614–13619.
37. Cureton, D.K.; Massol, R.H.; Saffarian, S.; Kirchhausen, T.L.; Whelan, S.P. Vesicular stomatitis virus enters cells through vesicles incompletely coated with clathrin that depend upon actin for internalization. PLoS Pathog. 2009, 5, e1000394, doi:10.1371/journal.ppat.1000394.
38. Lakadamyali, M.; Rust, M.J.; Zhuang, X. Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell 2006, 124, 997–1009.
39. Vodicka, M.A.; Goh, W.C.; Wu, L.I.; Rogel, M.E.; Bartz, S.R.; Schweickart, V.L.; Raport, C.J.; Emerman, M. Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses. Virology 1997, 233, 193–198.
40. Perron, M.J.; Stremlau, M.; Song, B.; Ulm, W.; Mulligan, R.C.; Sodroski, J. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc. Natl. Acad. Sci. USA 2004, 101, 11827–11832.
41. Bérubé, J.; Bouchard, A.; Berthoux, L. Both TRIM5alpha and TRIMCyp have only weak antiviral activity in canine D17 cells. Retrovirology 2007, 4, 68, doi:10.1186/1742-4690-4-68.
42. Fricke, T.; White, T.E.; Schulte, B.; de Souza Aranha Vieira, D.A.; Dharan, A.; Campbell, E.M.; Brandariz-Nunez, A.; Diaz-Griffero, F. MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1. Retrovirology 2014, 11, 68, doi:10.1186/s12977-014-0068-x.
43. Lukic, Z.; Dharan, A.; Fricke, T.; Diaz-Griffero, F.; Campbell, E.M. HIV-1 Uncoating is Facilitated by Dynein and Kinesin-1. J. Virol. 2014, doi:10.1128/JVI.02219-14.
44. Burkhardt, J.K.; Echeverri, C.J.; Nilsson, T.; Vallee, R.B. Overexpression of the dynamitin (p50) subunit of the dynactin complex disrupts dynein-dependent maintenance of membrane organelle distribution. J. Cell Biol. 1997, 139, 469–484.
45. Melkonian, K.A.; Maier, K.C.; Godfrey, J.E.; Rodgers, M.; Schroer, T.A. Mechanism of dynamitin-mediated disruption of dynactin. J. Biol. Chem. 2007, 282, 19355–19364.
46. Blair, W.S.; Pickford, C.; Irving, S.L.; Brown, D.G.; Anderson, M.; Bazin, R.; Cao, J.; Ciaramella, G.; Isaacson, J.; Jackson, L. et al. HIV capsid is a tractable target for small molecule therapeutic intervention. PLoS Pathog. 2010, 6, e1001220, doi:10.1371/journal.ppat.1001220.
47. Kim, S.Y.; Byrn, R.; Groopman, J.; Baltimore, D. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: Evidence for differential gene expression. J. Virol. 1989, 63, 3708–3713.
48. Zennou, V.; Petit, C.; Guetard, D.; Nerhbass, U.; Montagnier, L.; Charneau, P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 2000, 101, 173–185.
49. Butler, S.L.; Hansen, M.S.; Bushman, F.D. A quantitative assay for HIV DNA integration in vivo. Nat. Med. 2001, 7, 631–634.
50. Pauza, C.D.; Trivedi, P.; McKechnie, T.S.; Richman, D.D.; Graziano, F.M. 2-LTR circular viral DNA as a marker for human immunodeficiency virus type 1 infection in vivo. Virology 1994, 205, 470–478.
51. Hulme, A.E.; Hope, T.J. The cyclosporin A washout assay to detect HIV-1 uncoating in infected cells. Methods Mol. Biol. 2014, 1087, 37–46.
52. Yufenyuy, E.L.; Aiken, C. The NTD-CTD intersubunit interface plays a critical role in assembly and stabilization of the HIV-1 capsid. Retrovirology 2013, 10, 29, doi:10.1186/1742-4690-10-29.
53. Fassati, A. Multiple roles of the capsid protein in the early steps of HIV-1 infection. Virus Res. 2012, 170, 15–24.
54. Arhel, N. Revisiting HIV-1 uncoating. Retrovirology 2010, 7, 96, doi: 10.1186/1742-4690-7-96.
55. De Iaco, A.; Luban, J. Cyclophilin A promotes HIV-1 reverse transcription but its effect on transduction correlates best with its effect on nuclear entry of viral cDNA. Retrovirology 2014, 11, 11, doi:10.1186/1742-4690-11-11.
56. Dismuke, D.J.; Aiken, C. Evidence for a functional link between uncoating of the human immunodeficiency virus type 1 core and nuclear import of the viral preintegration complex. J. Virol. 2006, 80, 3712–3720.
57. Krishnan, L.; Matreyek, K.A.; Oztop, I.; Lee, K.; Tipper, C.H.; Li, X.; Dar, M.J.; Kewalramani, V.N.; Engelman, A. The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase. J. Virol. 2010, 84, 397–406.
58. Meehan, A.M.; Saenz, D.T.; Guevera, R.; Morrison, J.H.; Peretz, M.; Fadel, H.J.; Hamada, M.; van Deursen, J.; Poeschla, E.M. A cyclophilin homology domain-independent role for Nup358 in HIV-1 infection. PLoS Pathog. 2014, 10, e1003969, doi:10.1371/journal.ppat.1003969.
59. Bichel, K.; Price, A.J.; Schaller, T.; Towers, G.J.; Freund, S.M.; James, L.C. HIV-1 capsid undergoes coupled binding and isomerization by the nuclear pore protein NUP358. Retrovirology 2013, 10, 81, doi:10.1186/1742-4690-10-81.
60. Yoder, A.; Guo, J.; Yu, D.; Cui, Z.; Zhang, X.E.; Wu, Y. Effects of microtubule modulators on HIV-1 infection of transformed and resting CD4 T cells. J. Virol. 2011, 85, 3020–3024.
61. Nepveu-Traversy, M.E.; Berube, J.; Berthoux, L. TRIM5alpha and TRIMCyp form apparent hexamers and their multimeric state is not affected by exposure to restriction-sensitive viruses or by treatment with pharmacological inhibitors. Retrovirology 2009, 6, 100, doi:10.1186/1742-4690-6-100.
62. Schrader, M.; King, S.J.; Stroh, T.A.; Schroer, T.A. Real time imaging reveals a peroxisomal reticulum in living cells. J. Cell Sci. 2000, 113 Pt 20, 3663–3671.
63. Berthoux, L.; Towers, G.J.; Gurer, C.; Salomoni, P.; Pandolfi, P.P.; Luban, J. As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity. J. Virol. 2003, 77, 3167–3180.
64. Naviaux, R.K.; Costanzi, E.; Haas, M.; Verma, I.M. The pCL vector system: Rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 1996, 70, 5701–5705.
65. Zufferey, R.; Nagy, D.; Mandel, R.J.; Naldini, L.; Trono, D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 1997, 15, 871–875.
66. He, J.; Chen, Y.; Farzan, M.; Choe, H.; Ohagen, A.; Gartner, S.; Busciglio, J.; Yang, X.; Hofmann, W.; Newman, W. et al. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature 1997, 385, 645–649.
67. Veillette, M.; Bichel, K.; Pawlica, P.; Freund, S.M.; Plourde, M.B.; Pham, Q.T.; Reyes-Moreno, C.; James, L.C.; Berthoux, L. The V86M mutation in HIV-1 capsid confers resistance to TRIM5alpha by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import. Retrovirology 2013, 10, 25, doi:10.1186/1742-4690-10-25.
68. GraphPad Prism, version 5.00 for Windows; GraphPad Software: San Diego, CA, USA, 2007.
69. Spitzer, M.; Wildenhain, J.; Rappsilber, J.; Tyers, M. BoxPlotR: A web tool for generation of box plots. Nat. Methods 2014, 11, 121–122.